ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,474.31
0.74%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.712
0.09%
Brent Oil
83.545
0.51%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Coeptis Therapeutics Holdings Inc (COEP)

  7. Coeptis Therapeutics Holdings Inc (COEP) ニュース

COEP

Coeptis Therapeutics (COEP)

Coeptis Therapeutics Holdings Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:COEP
日付受信時刻ニュースソース見出しコード企業名
2024/05/0221 : 47PR Newswire (US)Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2024/04/0221 : 47PR Newswire (US)Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research AwardNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2024/02/2623 : 00PR Newswire (US)Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NKNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2024/02/0721 : 30PR Newswire (US)Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral InfectionsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2024/01/0421 : 30PR Newswire (US)Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024NASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/10/3122 : 01PR Newswire (US)Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023NASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/10/2421 : 30PR Newswire (US)Coeptis Therapeutics Announces $2 Million Private PlacementNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/10/1120 : 30PR Newswire (US)Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell TechnologyNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/10/0922 : 15PR Newswire (US)Coeptis Therapeutics to Participate in Panel at the BioFlorida Conference Discussing Emerging Cell and Gene TherapiesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/10/0420 : 30PR Newswire (US)Coeptis Therapeutics Announces Research Involving SNAP-CAR Accepted for Presentation at the Society for Immunotherapy of Cancer's 38th Annual MeetingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/09/2720 : 30PR Newswire (US)Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the MesaNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/09/1420 : 30PR Newswire (US)Coeptis Therapeutics Provides Safety and Dosing Update from Phase 1 Trials Investigating DVX201 in Relapsed/Refractory AML or High Risk MDS and Hospitalized COVID-19 InfectionNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/09/1120 : 30PR Newswire (US)Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington's Cancer Research EndowmentNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/08/3102 : 00PR Newswire (US)Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical OfficerNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/08/1720 : 30PR Newswire (US)Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra TherapeuticsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/08/0121 : 00PR Newswire (US)Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion DiagnosticNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/06/1705 : 00PR Newswire (US)Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten OfferingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/06/1422 : 28PR Newswire (US)Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten OfferingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/06/0920 : 00PR Newswire (US)Coeptis Therapeutics Receives Approval to Transfer to The Nasdaq Capital MarketNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/05/1721 : 30PR Newswire (US)Coeptis Therapeutics Appoints Brian Cogley as Chief Financial OfficerNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/05/1104 : 00PR Newswire (US)Coeptis Therapeutics' SNAP-CAR Technology Platform for Programmable Antigen Targeting Featured in Peer-Reviewed Article in Nature CommunicationsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/04/1820 : 30PR Newswire (US)Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra TherapeuticsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/03/2922 : 45PR Newswire (US)Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment StrategiesNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/03/2120 : 00PR Newswire (US)Coeptis Therapeutics' SNAP-CAR Technology Platform Highlighted in Peer-Reviewed Article in Translational MedicineNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/02/0722 : 00PR Newswire (US)Coeptis Therapeutics and ShareIntel Enter Shareholder Service Agreement, Targeting Illegal Short SellingNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2023/01/3122 : 45PR Newswire (US)Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development ProgramNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2022/11/2221 : 00PR Newswire (US)Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development ProgramNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2022/11/1521 : 00PR Newswire (US)Coeptis Therapeutics Holdings to Ring the Nasdaq Stock Market Opening BellNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2022/11/0821 : 00PR Newswire (US)Coeptis Therapeutics' Scientific Advisory Board Members Featured on "Biology of Natural Killer (NK) Cells" PodcastNASDAQ:COEPCoeptis Therapeutics Holdings Inc
2022/11/0220 : 00PR Newswire (US)Coeptis Therapeutics Holdings Expands Board of Directors with New AppointmentsNASDAQ:COEPCoeptis Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:COEP

最近閲覧した銘柄

NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
FX
USDJPY
US Dollar vs Yen
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有